Tvardi Therapeutics, Inc. (TVRD) stock
TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01−0.09 (-8.18%)
Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%
Tvardi Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Tvardi Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.9× to 20.6×, with a median of 7.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | +0.1 |
| 2025 | Dec 31, 2025 | 1.4× | +0.4 |
| 2024 | Jan 31, 2024 | 1.1× | −0.3 |
| 2023 | Dec 29, 2023 | 1.4× | −8.0 |
| 2022 | Dec 30, 2022 | 9.4× | +0.5 |
| 2021 | Dec 31, 2021 | 8.8× | −7.8 |
| 2020 | Dec 31, 2020 | 16.6× | +6.0 |
| 2019 | Dec 31, 2019 | 10.6× | +0.4 |
| 2018 | Dec 31, 2018 | 10.3× | −1.8 |
| 2017 | Dec 29, 2017 | 12.1× | +1.5 |
| 2016 | Dec 30, 2016 | 10.6× | −1.5 |
| 2015 | Dec 31, 2015 | 12.1× | −0.2 |
| 2014 | Dec 31, 2014 | 12.3× | – |
See a number that looks wrong?